Ovidiu C Andronesi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Spectroscopy | 36 | 2022 | 3759 | 4.560 |
Why?
|
| Glutarates | 8 | 2021 | 236 | 3.320 |
Why?
|
| Isocitrate Dehydrogenase | 13 | 2023 | 871 | 2.800 |
Why?
|
| Glioma | 15 | 2023 | 3401 | 2.470 |
Why?
|
| Brain Neoplasms | 25 | 2023 | 8861 | 1.780 |
Why?
|
| Imaging, Three-Dimensional | 14 | 2020 | 4042 | 1.580 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 8 | 2013 | 506 | 1.250 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2022 | 35425 | 1.220 |
Why?
|
| Brain | 23 | 2021 | 26388 | 1.120 |
Why?
|
| Signal Processing, Computer-Assisted | 7 | 2016 | 1534 | 0.890 |
Why?
|
| Image Processing, Computer-Assisted | 10 | 2020 | 8949 | 0.780 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2020 | 1121 | 0.780 |
Why?
|
| Consensus | 7 | 2023 | 2960 | 0.760 |
Why?
|
| Brain Chemistry | 5 | 2018 | 982 | 0.750 |
Why?
|
| Motion | 4 | 2020 | 798 | 0.660 |
Why?
|
| Molecular Imaging | 4 | 2016 | 828 | 0.580 |
Why?
|
| Metabolome | 5 | 2020 | 895 | 0.530 |
Why?
|
| Phantoms, Imaging | 8 | 2021 | 2480 | 0.510 |
Why?
|
| Glioblastoma | 10 | 2021 | 3481 | 0.490 |
Why?
|
| Water | 2 | 2021 | 1395 | 0.430 |
Why?
|
| Image Enhancement | 4 | 2016 | 2921 | 0.410 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2020 | 3326 | 0.390 |
Why?
|
| Spin Labels | 5 | 2016 | 332 | 0.380 |
Why?
|
| Mutation | 12 | 2023 | 29786 | 0.380 |
Why?
|
| Artifacts | 7 | 2018 | 1904 | 0.370 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2016 | 1624 | 0.360 |
Why?
|
| Contrast Media | 5 | 2017 | 5300 | 0.340 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 321 | 0.330 |
Why?
|
| Dextrans | 1 | 2010 | 595 | 0.320 |
Why?
|
| Transducers | 1 | 2010 | 252 | 0.320 |
Why?
|
| Wound Infection | 1 | 2010 | 242 | 0.320 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 3799 | 0.290 |
Why?
|
| Lipid Bilayers | 2 | 2008 | 381 | 0.280 |
Why?
|
| Expert Testimony | 4 | 2021 | 356 | 0.270 |
Why?
|
| Gramicidin | 1 | 2004 | 12 | 0.260 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14723 | 0.250 |
Why?
|
| Calcium-Binding Proteins | 2 | 2008 | 1081 | 0.240 |
Why?
|
| Genomics | 3 | 2018 | 5717 | 0.240 |
Why?
|
| Thermodynamics | 1 | 2005 | 594 | 0.240 |
Why?
|
| Inositol | 2 | 2021 | 218 | 0.210 |
Why?
|
| Burns | 2 | 2010 | 1815 | 0.210 |
Why?
|
| Humans | 57 | 2023 | 744366 | 0.210 |
Why?
|
| Algorithms | 6 | 2016 | 13882 | 0.190 |
Why?
|
| Adult | 23 | 2023 | 214052 | 0.190 |
Why?
|
| Electronics | 1 | 2021 | 322 | 0.180 |
Why?
|
| Reproducibility of Results | 12 | 2021 | 19905 | 0.180 |
Why?
|
| Male | 25 | 2021 | 350115 | 0.170 |
Why?
|
| Female | 26 | 2021 | 380193 | 0.170 |
Why?
|
| tau Proteins | 1 | 2008 | 1868 | 0.160 |
Why?
|
| Phosphocreatine | 2 | 2016 | 269 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2021 | 2038 | 0.160 |
Why?
|
| Echo-Planar Imaging | 2 | 2013 | 659 | 0.160 |
Why?
|
| Protein Structure, Secondary | 5 | 2008 | 1247 | 0.160 |
Why?
|
| Brain Mapping | 1 | 2013 | 6670 | 0.160 |
Why?
|
| Research Report | 1 | 2021 | 355 | 0.150 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 91 | 0.150 |
Why?
|
| Macrophages | 2 | 2017 | 5660 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 13693 | 0.140 |
Why?
|
| Fibromyalgia | 1 | 2021 | 388 | 0.140 |
Why?
|
| Head Movements | 1 | 2017 | 150 | 0.140 |
Why?
|
| Protons | 3 | 2019 | 1127 | 0.140 |
Why?
|
| Head | 1 | 2021 | 880 | 0.130 |
Why?
|
| Mitochondria, Muscle | 1 | 2016 | 171 | 0.130 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2020 | 518 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 648 | 0.120 |
Why?
|
| Quinazolines | 2 | 2011 | 1356 | 0.120 |
Why?
|
| Muscle, Skeletal | 3 | 2016 | 4925 | 0.110 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 895 | 0.110 |
Why?
|
| Peptides | 1 | 2004 | 4410 | 0.110 |
Why?
|
| Lymphoma | 1 | 2021 | 1877 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2018 | 956 | 0.100 |
Why?
|
| Middle Aged | 17 | 2021 | 213390 | 0.100 |
Why?
|
| Biopsy | 4 | 2012 | 6755 | 0.100 |
Why?
|
| Lasers | 1 | 2015 | 952 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 409 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2011 | 2327 | 0.090 |
Why?
|
| Prospective Studies | 5 | 2021 | 53290 | 0.090 |
Why?
|
| Computer Simulation | 4 | 2011 | 6194 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4933 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 2513 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 2765 | 0.090 |
Why?
|
| Neoplasm Staging | 3 | 2015 | 11031 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2015 | 1005 | 0.080 |
Why?
|
| Nitrogen Isotopes | 2 | 2005 | 84 | 0.080 |
Why?
|
| Regeneration | 1 | 2017 | 1485 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2204 | 0.080 |
Why?
|
| Carbon Isotopes | 2 | 2005 | 467 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1828 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2008 | 354 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2008 | 126 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 868 | 0.070 |
Why?
|
| Young Adult | 7 | 2020 | 56429 | 0.070 |
Why?
|
| Glycine | 1 | 2010 | 671 | 0.070 |
Why?
|
| Rhodopsin | 1 | 2007 | 203 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2010 | 613 | 0.070 |
Why?
|
| Photoaffinity Labels | 1 | 2005 | 86 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2016 | 2897 | 0.060 |
Why?
|
| Glutamic Acid | 2 | 2021 | 1169 | 0.060 |
Why?
|
| Gene Expression | 1 | 2018 | 7798 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 365 | 0.060 |
Why?
|
| Molecular Probes | 1 | 2005 | 316 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3848 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 626 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2017 | 2775 | 0.060 |
Why?
|
| Computer Systems | 2 | 2016 | 483 | 0.050 |
Why?
|
| Artificial Intelligence | 2 | 2012 | 2213 | 0.050 |
Why?
|
| Equipment Design | 1 | 2010 | 3582 | 0.050 |
Why?
|
| Anisotropy | 1 | 2004 | 1265 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9240 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9445 | 0.050 |
Why?
|
| Exercise | 1 | 2016 | 5615 | 0.050 |
Why?
|
| Epilepsy | 2 | 2012 | 3310 | 0.040 |
Why?
|
| alpha-Synuclein | 1 | 2005 | 722 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 4851 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 2020 | 379 | 0.040 |
Why?
|
| Misonidazole | 1 | 2018 | 34 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 8432 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2020 | 454 | 0.040 |
Why?
|
| Calibration | 1 | 2020 | 816 | 0.040 |
Why?
|
| Dipeptides | 1 | 2020 | 409 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2008 | 5451 | 0.040 |
Why?
|
| Movement | 2 | 2017 | 1471 | 0.040 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2645 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4253 | 0.040 |
Why?
|
| Phosphorus Isotopes | 1 | 2016 | 126 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2007 | 3749 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 579 | 0.040 |
Why?
|
| Animals | 5 | 2017 | 168768 | 0.030 |
Why?
|
| Prognosis | 3 | 2018 | 29060 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 578 | 0.030 |
Why?
|
| Physical Phenomena | 1 | 2014 | 46 | 0.030 |
Why?
|
| Creatinine | 1 | 2020 | 1919 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1357 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2021 | 6234 | 0.030 |
Why?
|
| Aged | 6 | 2020 | 163288 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 57776 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2020 | 986 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 647 | 0.030 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 768 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 81201 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2013 | 5077 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3528 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2016 | 1578 | 0.020 |
Why?
|
| Phosphorus | 1 | 2011 | 338 | 0.020 |
Why?
|
| Rotation | 1 | 2011 | 523 | 0.020 |
Why?
|
| Creatine | 1 | 2011 | 421 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 576 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2009 | 265 | 0.020 |
Why?
|
| Monocytes | 1 | 2017 | 2596 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2012 | 790 | 0.020 |
Why?
|
| Halobacteriaceae | 1 | 2007 | 1 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8038 | 0.020 |
Why?
|
| Software | 1 | 2021 | 4441 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2013 | 2879 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2005 | 70 | 0.020 |
Why?
|
| Leg | 1 | 2011 | 1116 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15078 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13991 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2005 | 291 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18034 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 4982 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2005 | 624 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2649 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2005 | 562 | 0.020 |
Why?
|
| Adolescent | 2 | 2010 | 85779 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21748 | 0.010 |
Why?
|
| Amino Acids | 1 | 2009 | 1737 | 0.010 |
Why?
|
| Meningioma | 1 | 2012 | 1209 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 2732 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 2737 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14561 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2005 | 1899 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 1889 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 4320 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40075 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3921 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 6476 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 4010 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11366 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13409 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13814 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18111 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 9724 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 21833 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9584 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 77460 | 0.000 |
Why?
|